Background: Diarrhea is one of the most common ailments afflicting travelers with attack rates of 30-40% for medium to high-risk destinations. As travelers' diarrhea (TD) is syndromic and caused by a wide range of pathogens, including bacteria, parasites and viruses, multiplex deoxyribonucleic acid (DNA) extraction polymerase chain reaction (PCR) technology can be useful for determining the etiology of TD pathogens. Objective: The goal of this retrospective study was to produce clinically relevant and useful data on gastrointestinal illness related to travel identified by culture-independent methods of diagnosis-use of the multiplex DNA extraction PCR platform (BioFire FilmArray GI Panel) and to describe the use of this technology in detection of enteric pathogens. Method: We reviewed our data in returned travelers from May 2014 to March 2017, looking at demographics, country of travel, number of pathogens found and pathogens by specific region. Results: Stool analysis by DNA extraction PCR was obtained in 388 post-travel patients. Three hundred and twentyseven of these had diarrhea or other enteric symptoms. Sixty-one travelers presented with enteric symptoms and were diagnosed with post infectious irritable bowel syndrome (PI-IBS) after stool analyses were negative. Of those with diarrhea or gastrointestinal (GI) symptoms and excluding those diagnosed with PI-IBS, 207 patients tested positive for at least 1 enteric pathogen (63.4%). Eighty of those patients were found to have multiple pathogens. Viral pathogens were identified in 38 patients, 18% of the total number of cases. Conclusion: The BioFire FilmArray GI Panel was associated with better detection of pathogens than historical controls while also allowing prompt and accurate diagnosis and potential treatment. A higher proportion of viral pathogens compared with historical assumptions was identified as well as mixed infections with multiple pathogens, a phenomenon largely unknown to clinicians before this technology became available.
Introduction
Diarrhea is one the most common ailments afflicting travelers with attack rates of 30-40% in travelers to moderate-to-high risk destination. 1 Travelers' diarrhea (TD) has historically been considered primarily a bacterial illness with diarrheagenic Escherichia coli, Campylobacter, Shigella and Salmonella being the primary pathogens. 2 Community acquired diarrhea in developed countries, such as those of Western Europe and the USA have historically been caused by viral pathogens, most commonly norovirus. 3, 4 Traditional methods of diagnosis of enteric pathogens fail to reveal the etiology in the majority of cases of acute diarrheal infection. In TD in particular, specific etiologic agents are found in <50% of the time. [5] [6] [7] There are several reasons for this. Traditional diagnostic methods such as bacterial culture often fail to reveal enteropathogens particularly in the setting of antibiotic use. 8 In addition, for certain pathogens such as Campylobacter, isolation may be hampered by the presence of normal stool flora, requiring selective techniques which in turn may limit the detection of other pathogens. In addition, bacterial culture is not widely available for some of the more common pathogens such as the diarrheagenic E.coli. 5, 8 Lastly, bacterial culture is time consuming with results often not available for 48-72 h. The diagnosis of intestinal parasites has serious limitations as well. Identification of these organisms depends to some extent on the life cycle of the parasite and multiple specimens are often required to reduce the day to day variability in parasite shedding. 9, 10 The need for a rapid specific and sensitive diagnostic method has been apparent for quite some time. 8 Recently, cultureindependent methods of diagnosis have become available for evaluation of etiologic agents of travelers' diarrhea and community-acquired diarrhea. [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Data were reviewed in returning travelers for the period from May 2014 to March 2017 for whom stool specimens were obtained and analyzed by a high throughput multiplex deoxyribonucleic acid (DNA) extraction polymerase chain reaction (PCR) platform (BioFire FilmArray GI panel).
Methods
This retrospective study was conducted at The New York Center for Travel and Tropical Medicine, a private medical practice that specializes in Travel and Tropical Medicine and Gastroenterology. Data used for the study included patient demographics, travel destination, pathogens and number of pathogens found in each patient, as well as pathogens by specific country and region.
Participants
Participants for this study included men, women and children.
Gender and age of all participants were documented.
Materials
Data collection method Patients were selected based on their symptom presentation and history of travel. All participants were returning travelers who presented to the clinic with diarrhea and/or other enteric symptoms (abdominal pain, nausea/vomiting, bloating, abdominal cramping) shortly after their trip. Diarrhea was defined as a change in bowel movement frequency associated with a decrease in form of passed stool bothersome enough to seek medical attention. We studied patients with diarrhea which was acute, persistent and chronic post travel. Most patients with chronic diarrhea were negative on Film Array and diagnosed with post infectious irritable bowel syndrome (PI-IBS). PI-IBS is defined as the persistence of gastrointestinal symptoms characterized by a change in bowel habits following a bout of TD or gastroenteritis where no pathogen is identified and underlying gastrointestinal disease is excluded. All participants were required to provide information specific to age, gender, travel dates, travel destinations, detailed description of symptoms, activities during travel and date of symptom onset. Each participant was interviewed by a healthcare provider during the initial office visit. Eligibility for testing by DNA extraction PCR BioFire FilmArray was determined after complete patient examination and evaluation of onset of symptoms and their relationship to travel dates, travel destinations and severity of symptoms.
Specimen collection methods
Stool specimens were obtained from patients in two ways:
(1) Patients provided a specimen collected in a Cary Blair transport medium vial during visit.
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(2) Specimen was collected from patients during examination by using a fecal swab that was transferred into a Cary Blair transport medium vial.
Specimen inclusion criteria All specimens were tested within 4 days after collection.
Equipment Each stool specimen was tested by using a high throughput DNA extraction PCR FilmArray GI Panel. The FilmArray system is integrated and includes automated sample preparation. All reagents needed for sample preparation, reverse transcription, PCR and detection are provided freeze-dried in a single-use pouch. 23 Stool specimens were stored at room temperature 20-25°C until FilmArray GI Panel testing could be completed. At least 200 µl of specimen (stool specimen mixed in Cary-Blair transport medium) was subject to FilmArray GI Panel testing, according to the manufacturer's instructions. Before inserting the reagent pouch into the analyzer, the sample is combined with sample buffer and is injected into the pouch along with a hydration solution. After the pouch has been inserted, the system automatically processes a sample through the following stages: nucleic acid purification, broad-range reverse transcription PCR, second-stage 'nested' PCR with speciesspecific primers and detection with melting curve analysis. The system extracts and purifies nucleic acids, which then undergo reverse transcription and are amplified in the first broad-range PCR reaction. A second nested PCR reaction containing species-specific primers is run to detect and identify any pathogens in the sample by fluorescence. 
Results
Stool analysis by DNA extraction PCR was obtained in 388 posttravel patients from May 2014 to March 2017. Three hundred and twenty-seven patients had specimens analyzed for the purpose of this study whereas 61 patients were diagnosed with PI-IBS and were excluded from the study. Of 327 travelers, 196 were female (ages 1-81) and 131 were male (ages 1-83). Of the 327 analyzed specimens, 207 (63.4%) were positive for enteric pathogens on the FilmArray GI Panel. Of these, 116 were female (ages 1-81) and 93 were male (ages 1-82). For 27 out of 207 patients who tested positive, country of exposure could not be identified as these travelers took multiple trips within a short period of time and therefore their exact region of exposure remains uncertain. Multiple pathogens were noted in 80 of the 207 positive patients (38%). Of these, 48 were females ages 1-70, and 32 were males ages 1-71. Two pathogens were found in 47 patients, 3 pathogens in 21 patients, 4 pathogens in 10 patients and 5 pathogens were found in 2 patients.
There were 79 countries visited in total by patients with diarrhea. Sixty-eight countries were associated with positive findings on FilmArray. Mexico, the Dominican Republic, and India were the most frequented countries in patients with diarrheal pathogens ( Figure 1 ). All countries visited by the 327 patients with diarrhea are classified by region and listed in Table 1 .
The most common pathogens found included the diarrheagenic E. coli while other bacterial pathogens included Enteroinvasive E. coli/Shigella, Campylobacter, Shiga toxin producing E. Coli (STEC:non 0157), Plesiomonas shigelloides, Salmonella, Yersinia enterocolitica, Vibrio and Enterohemorrhagic E. coli (EHEC 0157) (Figure 2) .
Of the parasitic causes, Giardia lamblia was most common (Figure 3) . Also identified were Cryptosporidium and Cyclospora. Interestingly, not one case of E. histolytica was identified. Parasites were identified in 25 patients and comprise 12% of the total number of positive cases.
Viral pathogens were identified in 38 patients, comprising 18% of the total number of cases: norovirus, sapovirus, adenovirus F40/41, and astrovirus ( Figure 4) . Viral pathogens were predominantly found in North America and the Caribbean, with majority of viral pathogens identified in travelers returning from Mexico (5), Dominican Republic (4) and Haiti (4). Parasitic pathogens were almost equally identified in travelers returning from Dominican Republic (3), Mexico (2), Myanmar (2), Democratic Republic of Congo (2), USA (2), Guatemala (1), Brazil (1), Fiji (1), Costa Rica (1), Iceland (1), India (1), Nepal (1), Switzerland (1), Mongolia (1), Senegal (1) and United Arab Emirates (1), with 1-3 cases identified for each country. Bacterial pathogens were most commonly found in patients who returned from North America (mainly from Mexico [29] ), South America (mainly from Colombia [10] ), Central America (mainly from Guatemala [4] ), Caribbean Islands (mainly from Dominican Republic [10] ), South-East Asia (mainly from India [9] ) and Sub-Saharan Africa (mainly from Democratic Republic of Congo [3] and Nigeria [3] ).
Colombia, Dominican Republic, India and Mexico presented with the highest number of patient cases in which multiple pathogens were identified.
Out of 21 patients who tested positive for Clostridium difficile, 11 took antibiotics prior to the onset of symptoms. Three patients took antibiotics 2 weeks prior; 2 patients took antibiotics 1-2 months prior; 6 patients reported taking antibiotics more than 5 months prior to symptom onset. Most commonly used antibiotics included amoxicillin, ciprofloxacin, paromomycin and azithromycin. However, previous antibiotic use could not be identified as a definite cause of infection by C. difficile in these travelers. 
Discussion
Culture-independent diagnostics allow for a more rapid and reliable identification of potential pathogens responsible for TD. We found that the proportion of patients with viral pathogens was higher than the historical etiologic data of 8-15% obtained using standard microbiological techniques. [26] [27] [28] In addition, infection with multiple pathogens in a given individual is a phenomenon many practicing clinicians were largely unaware of before this technology became available. This may manifest itself as a patient who has the typical onset of bacterial diarrhea in the first few days of travel, and then a 'second wave' of diarrhea occurring a week or two later, which may be related to a protozoan pathogen such as Giardia or Cryptosporidium which may have been ingested at the same meal that caused the initial bacterial diarrhea.
This highlights what may be regarded as a limitation of this technology: interpretation of results complicated by a higher (12); STEC (Shiga-like toxin-producing E. coli stx1/stx2 [9] ); Plesiomonas shigelloides (6); Salmonella (6); Yersinia enterocolitica (4); Vibrio (3); E. coli O157 (Enterohemorrhagic E. coli O157 [2] ); Vibrio cholerae (has not been identified among travel patients during study). than expected rate of mixed infection, background carriage in many communities, and the necessity of being able to distinguish pathogens which are causing current symptoms from those which are no longer viable or causing pathogenesis. 29 The significance of identified organisms may be unclear as these nucleic acid techniques do not differentiate between viable and nonviable organisms and can detect microbes at non-pathogenic levels. Given the high rates of asymptomatic carriage, this may be a problem. Specifically addressing the relative importance of multiple organisms is something which may require a degree of clinical expertise not widely available.
Enteric infections have largely been conceptualized as occurring in a binary state: either the pathogen is present in the gut or not, but these point of care diagnostics seem to provide a broader picture of infection and a new understanding of the concept of pathogenesis requiring a reconsideration of the basic notions of colonization, infection and disease. 17, 30 A clear advantage of this method of testing is that PCR does not require a culturable organism and the test is not affected by prolonged sample transportation which makes it especially useful for specimen collection in the field. Several of our travelers had specimens obtained during their travel and analyzed upon their return. Also, the concurrent use of antibiotics or bismuth does not appear to affect the reliability of this assay. 24 One limitation of our study is that the multiplex PCR lack targets for some causes of diarrhea which might be regionally important, such as Dientamoeba fragilis or Microsporidia or novel bacteria such as Laribacter or Arcobacter.
In summary, the use of a high throughput multiplex DNA extraction PCR technology (BioFire Film Array GI Panel) was associated with higher rates of microbial detection than traditional methods and in a much shorter time frame to diagnosis. An increase in viral and protozoan pathogens compared with our historical assumptions was noted in our returned travelers but more data with this technology across multiple destinations will be required before this can be verified as a trend. A high proportion of returned travelers with mixed infections was noted, a phenomenon we were largely unaware of prior to this technology.
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